466
Participants
Start Date
October 14, 2016
Primary Completion Date
May 9, 2024
Study Completion Date
February 6, 2028
CC-220
Specified dose on specified days
Dexamethasone
Specified dose on specified days
Daratumumab
Specified dose on specified days
Bortezomib
Specified dose on specified days
Carfilzomib
Specified dose on specified days
Local Institution - 852, Box Hill
Local Institution - 854, Adelaide
Local Institution - 121, New York
Local Institution - 109, New York
Local Institution - 111, New York
Local Institution - 301, Torino
Local Institution - 122, Mineola
Local Institution - 125, Rochester
Local Institution - 116, Philadelphia
Local Institution - 604, Hamburg
Local Institution - 106, Baltimore
Local Institution - 305, Pavia
Local Institution - 408, Madrid
Local Institution - 407, Madrid
Local Institution - 112, Charlotte
Local Institution - 123, Greenville
Local Institution - 101, Atlanta
Local Institution - 402, Pamplona
Local Institution - 701, Pessac
Local Institution - 134, Memphis
Local Institution - 603, Düsseldorf
Local Institution - 302, Reggio Emilia
Local Institution - 124, Columbus
Local Institution - 117, Cleveland
Local Institution - 406, Valencia
Local Institution - 307, Meldola
Local Institution - 104, Ann Arbor
Local Institution - 103, Detroit
Local Institution - 754, Tel Litwinsky
Local Institution - 704, Lile Cedax
Local Institution - 120, Chicago
Local Institution - 755, Tel Aviv
Local Institution - 113, Fairway
Local Institution - 139, Papillion
Local Institution - 137, Omaha
Local Institution - 138, Omaha
Local Institution - 131, Omaha
Local Institution - 140, Grand Island
Local Institution - 141, Grand Island
Local Institution - 602, Heidelberg
Local Institution - 703, Pierre-Bénite
Local Institution - 601, Tübingen
Local Institution - 107, Little Rock
Local Institution - 118, Dallas
Local Institution - 102, Scottsdale
Local Institution - 702, Poitiers
Local Institution - 751, Jerusalem
Local Institution - 606, Würzburg
Local Institution - 126, Seattle
Local Institution - 132, Tacoma
Local Institution - 811, Nagasaki
Local Institution - 114, Boston
Local Institution - 115, Boston
Local Institution - 110, Boston
Local Institution - 756, Cherry Hill
Local Institution - 108, Hackensack
Local Institution - 119, Salt Lake City
Local Institution - 904, Calgary
Local Institution - 901, Vancouver
Local Institution - 902, Halifax
Local Institution - 903, Montreal
Local Institution - 605, Dresden
Local Institution - 303, Rome
Local Institution - 808, Matsuyama
Local Institution - 805, Aomori
Local Institution - 813, Hiroshima
Local Institution - 812, Isehara City, Kanagawa
Local Institution - 809, Kamogawa
Local Institution - 802, Kyoto
Local Institution - 810, Nagoya
Local Institution - 801, Nagoya
Local Institution - 804, Osaka
Local Institution - 815, Ōgaki
Local Institution - 803, Sendai
Local Institution - 806, Shinagawa-ku, Tokyo
Local Institution - 814, Sunto-gun
Local Institution - 807, Toyohashi
Local Institution - 503, Amsterdam
Local Institution - 504, Maastrich
Local Institution - 501, Rotterdam
Local Institution - 502, Utrecht
Local Institution - 404, Badalona (Barcelona)
Local Institution - 401, Barcelona
Local Institution - 405, Barcelona
Local Institution - 205, Birmingham
Local Institution - 202, Leeds
Local Institution - 204, Oxford
Local Institution - 201, Sutton
Local Institution - 203, Sutton
Lead Sponsor
Celgene
INDUSTRY